CBI Annual Meeting 2020 Online |
||||
| <Japanese> | >Oct. 27(Tue) >Oct. 28(Wed) >Oct. 29(Thu) >Oct. 30(Fri) |
（Update 2020.10.26） |
||
|
|||||||||||||
| Oct. 27 Tue |
Time | CH1 | CH2 | CH3 | CH4 | CH5 | |||||||
| 10:00-10:10 | Opening Remarks | ||||||||||||
| 10:10-10:30 | <Conference Chairperson> Chair: Shinichi Katakura(Keio University)
|
||||||||||||
| 10:30-12:00 | <Plenary Lecture> Chair: Shinichi Katakura(Keio University)
|
||||||||||||
| 12:00-13:00 | |
|
|||||||||||
| 13:00-14:30 | <Enterprise Session> ES-01 World Fusion Co., Ltd. |
<Enterprise Session> ES-02 Dotmatics Ltd |
<Enterprise Session> ES-03 Patcore, Inc. |
<Enterprise Session> ES-04 Bruker Japan K.K. |
<Enterprise Session> ES-05 DKSH Japan K.K. |
||||||||
| 14:45-16:15 | <Invited Talk> Chair: Toutai Mitsuyama (AIST)
|
<Symposium> SP-01 Japan Aerospace Exploration Agency(JAXA) |
<Symposium> SP-02 Japan Agency for Medical Research and Development(AMED) "Initiatives of AMED-BINDS for the drug discovery of COVID-19 infectious disease" |
<Focused Session> FS-01 Advanced Measurement and Analysis |
<Focused Session> FS-02 Origin of Life: Chemical Reactions and Information |
||||||||
| 16:30-18:00 | <Invited Talk> Chair: Midori Kamimura (Teijin Pharma Limited)
|
<Sponsored Session> SS-01 Amazon Web Services Japan K.K. |
<Symposium> SP-03 "Research activities for supporting drug discovery by in-silico unit of BINDS (AMED)" |
<Focused Session> FS-01 Advanced Measurement and Analysis |
|||||||||
|
|||||||||||||
| Oct. 28 Wed |
Time | CH1 | CH2 | CH3 | CH4 | CH5 | |||||||
| 10:00-12:00 | <Plenary Lecture> Chair: Koichi Takahashi (RIKEN)
|
||||||||||||
| 12:00-13:00 | |
||||||||||||
| 13:00-14:30 | <Enterprise Session> ES-06 MOLSIS Inc. |
<Enterprise Session> ES-07 Elix, Inc. |
<Enterprise Session> ES-08 FUJITSU KYUSHU SYSTEMS LIMITED |
<Enterprise Session> ES-09 Dassault Systemes K.K. |
|||||||||
| 14:45-16:15 | <Invited Talk> Chair: Teruki Honma (RIKEN)
|
<Sponsored Session> SS-02 Fujitsu Limited |
<Symposium> SP-04 "AI-based Substance Hazard Integrated Prediction System (AI-SHIPS) Project" (The Ministry of Economy, Trade and Industry, Research and Development) |
<Focused Session> FS-03 Neutron Probing Dynamics of Biomolecules, from Hydrogen at Active Site to Domain Correlation |
|||||||||
| 16:30-18:00 | <Sponsored Session> SS-03 National Institutes of Biomedical Innovation, Health and Nutrition(NIBIOHN) / Life Intelligence Consortium(LINC) |
<Symposium> SP-05 "Development of in vitro human body/tissue-mimicking model using high functional cell devices - Consideration for pharmacokinetic-oriented applications -" |
<Focused Session> FS-04 "Omics Principles" Committee |
||||||||||
|
|||||||||||||
| Oct. 29 Thu |
Time | CH1 | CH2 | CH3 | CH4 | CH5 | |||||||
| 10:00-11:30 | <Invited Talk> Chair: Tsukasa Ishihara (AIST)
|
<Symposium> SP-06 RIKEN "Introduction of GENESIS functions relevant for drug discovery" |
<Sponsored Session> SS-05 OpenEye Japan Co., Ltd. |
<Tutorial> TS-01 22th FMO seminar " Introduction of FMO database and analysis tutorial" |
|||||||||
| 11:30-11:45 | |
||||||||||||
| 11:45-13:15 | <Enterprise Session> ES-11 INFOCOM CORPORATION |
<Enterprise Session> ES-12 KISHIDA CHEMICAL Co.,Ltd. |
<Enterprise Session> ES-13 Amazon Web Services Japan K.K. |
<Enterprise Session> ES-14 G-Search Limited |
|||||||||
| 13:30-15:30 | <Plenary Lecture> Chair: Akihiko Konagaya (Keisen University)
|
||||||||||||
| 15:45-17:15 | <Oral Presentation 1> Clinical application/Regulatory Science Chair:Seiichi Ishida (Sojo University) O1-01 Mashiro Okunaka (Meiji Pharmaceutical University / National Cancer Center Hospital East) "Evaluation of the expression profile of diarrhea induced by irinotecan using the Japanese Adverse Drug Event Report Database" O1-02 Kaoru Sato (Lab Neuropharmacol, Div Pharmacol, NIHS) "Development of in vitro Blood Brain Barrier model reproducing microglia-induced cytokine/chemokine dynamics" O1-03 Shinichiro Horiuchi (National Institute of Health Sciences) "Establishment of culture protocol for application of human iPS cell-derived hepatocytes to cholestasis toxicity test" O1-04 Yukie Kuroda (National Institute of Health Sciences) "Long term culture using hepatocytes from chimeric mice with humanized livers for toxicity tests" |
<Oral Presentation 2> Drug Discovery application Chair: Teruki Honma (RIKEN) O2-01 Hiroshi Kawai (Socium Inc.) "Phenotypic Network Screening: A New High Throughput Screening Platform" O2-02 Daiki Erikawa (Tokyo Institute of Technology, School of Computing) "Development of Monte Carlo Tree Search Based small organic compound generation system" O2-03 Akihiro Masuda (Department of Biological Sciences, Graduate School of Science and Engineering, Chuo University) "Development of SSDB software for reproducing the ChEMBL database and its current status" O2-04 Tamio Mizukami (Nagahama Institute of Bio-Science and Technology) "Development of new AI-based cell visualization technology that can solve problems in drug discovery and regenerative medicine" |
<Oral Presentation 3> Molecular robotics Chair: Yusuke Sato (Tohoku University) O3-01 Nathanael Aubert-Kato (Ochanomizu University) "Automated exploration of CRN generating DNA structures" O3-02 Shuntaro Sato (School of Life Science and Technology, Tokyo Institute of Technology) "Optimization of the multi-step DNA computing reaction using oxDNA MD simulation" O3-03 Ibuki Kawamata (Tohoku University, Ochanomizu University) "Analysis of wireframe DNA nanostructure based on coarse-grained molecular dynamics simulated on a web server with simple interface" O3-04 Taisei Mori (Tohoku University) "Simulation of Self-replication System with Virtual Spring Model" |
||||||||||
| 17:30-19:00 | <Oral Presentation 4> Structural Bioscience Chair: Midori Kamimura (Teijin Pharma Limited) O1-05 Sandhya Tiwari (RIKEN Center for Computational Science) "Protocol for Assessing the Optimal Pixel Size to Improve the Accuracy of Single-Particle Cryo-Electron Microscopy Maps" O1-06 Yohta Fukuda (Graduate School of Pharmaceutical Science, Osaka University) "High-resolution neutron crystallography visualizes an OH-bound resting state of a copper-containing nitrite reductase" O1-07 Ken Morishima (Institute for Integrated Radiation and Nuclear Science, Kyoto University) "Innovative Small-Angle Scattering for Structural Analysis of Biomacromolecule in Solution" |
<Oral Presentation 5> Drug Discovery application Chair: Masakazu Sekijima (Tokyo Institute of Technology) O2-05 Taro Kakuzaki (Chugai Pharmaceuticals, Co., Ltd.) "Deep generative model for designing antibody from antibody library data" O2-06 Eri Wakai (Department of Integrative Pharmacology, Mie University Graduate School of Medicine) "Search for preventive drugs against Cisplatin-induced nephrotoxicity using public database and electronic medical records." O2-07 Takahiro Niimura (Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences) "Search for preventive drugs for drug-induced neuropathy using medical information database" |
<Oral Presentation 6> Molecular robotics/Computational Chemistry (Molecular Recognition) Chair: Ibuki Kawamata (Tohoku University), Kaori Fukuzawa (Hoshi University), Takatsugu Hirokawa (AIST) O3-05 Nicolas Lobato-Dauzier (Institute of Industrial Science, The University of Tokyo) "Temperature-based inputs for molecular reservoir computers" O3-06 Leo Cazenille (Department of Information Sciences, Ochanomizu University, Tokyo, Japan) "Exploring Self-Assembling Behaviors in a Swarm of Bio-micro-robots using Surrogate-Assisted MAP-Elites" O3-07 Yuma Handa (School of Pharmacy and Pharmaceutical Sciences, Hoshi University) "Prediction of Binding of Existing Drugs to SARS-CoV-2 Main Protease Using Molecular Dynamics and Fragment Molecular Orbital Calculations" |
||||||||||
|
|||||||||||||
| Oct. 30 Fri |
Time | CH1 | CH2 | CH3 | CH4 | CH5 | |||||||
| 10:00-12:00 | <Plenary Lecture> Chair: Midori Kamimura (Teijin Pharma Limited)
|
12:00-12:15 | The next year introduction | ||||||||||
| 12:15-13:00 | |
13:00-14:30 | <Oral Presentation 7> Drug Discovery/Clinical application (Focused on COVID-19) Chair: Shinichi Katakura (Keio University), Kaori Fukuzawa (Hoshi University), Takatsugu Hirokawa (AIST) O1-08 Ryo Hatada (Department of Chemistry & Research Center for Smart Molecules, Faculty of Science, Rikkyo University) "Interaction analyses between SARS-CoV-2 main protease and inhibitor N3 by using fragment molecular orbital method and molecular dynamics simulation" O1-09 Kazuki Akisawa (Department of Chemistry & Research Center for Smart Molecules, Faculty of Science,Rikkyo University) "Interaction analyses on SARS-CoV-2 spike proteins by using fragment molecular orbital method" O1-10 Nazim Medzhidov (Elix, Inc.) "Predicting inhibitors for SARS-CoV-2 RNA- dependent RNA polymerase using machine learning" O1-11 Mohini Yadav (Department of Engineering, Chiba Institute of Technology) "Theoretical insights into the molecular mechanism of NA-I117V-Mediated Oseltamivir Resistance in H5N1 Avian Influenza Virus" |
<Oral Presentation 8> ADMET/Others Chair: Takashi Mizuma (Teikyo Heisei University) O2-08 Yusuke Hoshino (Chiba University) "The prediction of food effect on drug oral absorption by machine learning" O2-09 Mizuki Nakamori (Graduate School of Pharmaceutical Sciences, Nagoya City University) "Prediction of the inhibitory activity of rat drug-metabolizing enzyme by in silico method" O2-10 Daitaro Misawa (SyntheticGestalt) "Introduction to the Issues of Dataset Construction in Pharmacokinetic Models" O2-11 Tetsuo Kitamura (Nonclinical Research Center, LSI Medience Corporation) "Analysis of monkey pose estimation using deep learning." |
<Oral Presentation 9> Bioinformatics Chair: Soichi Ogishima (Tohoku Medical Megabank Organization, Tohoku University), Kaoru Mogushi (Fujitsu Limited) O3-08 Shigeyuki Magi (Toho University) "Systems biological approaches to understand the mechanisms of cancer drug resistance & cardiotoxicity" O3-09 Satoshi Nagaie (Department of Informatics for Genomic Medicine, Tohoku Medical Megabank Organization, Tohoku University) "Development of phenotyping algorithm of type 2 diabetes mellitus: A retrospective claims database analysis" O3-10 Naoko Kasahara (Department of Informatics for Genomic Medicine, Tohoku Medical Megabank Organization, Tohoku University) "Integrated Database “dbTMM” with family linkage for stratification of cohort participants toward drug development" O3-11 Tsuyoshi Esaki (Shiga University) "Estimation of relationships between chemical substructures and gene expression antibiotic-resistance of bacteria: Adapting canonical correlation analysis for small sample data by gathered features using consensus clustering" |
||||||||
| 14:45-16:15 | <Oral Presentation 10> Computational Chemistry (Molecular Modeling) Chair: Takeshi Ishikawa (Kagoshima University) O1-12 Kentaro Takai (Fujitsu Ltd.) "Advanced methods to predict properties of cyclic peptides: conformation analysis of peptides cyclized by non-amide bonds" O1-13 Kei Moritsugu (Yokohama City University) "Enhanced conformational sampling of cyclic peptide Cyclorasin by coupled Nosé-Hoover equation" O1-14 Yuji Mochizuki (Department of Chemistry & Research Center for Smart Molecules, Faculty of Science, Rikkyo University & Institute of Industrial Science, University of Tokyo) "Development status of ABINIT-MP program in 2020" O1-15 Koji Okuwaki (Faculty of Science, Rikkyo University) "Development of multiscale FMO-DPD simulations for molecular design" |
<Oral Presentation 11> Data Science/Structure Activity Relationship Chair: Yoshihiro Uesawa (Meiji Pharmaceutical University), Kotaro Yuta (In Silico Data, Ltd.) O2-12 Haris Hasic (Department of Computer Science, School of Computing, Tokyo Institute of Technology) "Single-step Retrosynthesis Prediction based on the Identification of Potential Disconnection Sites" O2-13 Tomohiro Sato (Center for Biosystems Dynamics Research, RIKEN) "Deep neural network models to predict ion channel inhibitors with pre-learning of activity information of analogous proteins" O2-14 Ryota Jin (Laboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University) "Statistically estimating life-long progression of chronic disease from the information of short clinical trials" O2-15 Yasunari Matsuzaka (Department of Medical Molecular Informatics, Meiji Pharmaceutical University) "Prediction models of peroxisome proliferator-activated receptor-gamma through a deep learning-based QSAR analysis, DeepSnap" |
<Oral Presentation 12> Bioinformatics Chair: Yugo Shimizu (Keio University) O3-12 Satoshi Mizuno (Tohoku Medical Megabank Organization, Tohoku University) "Development of machine learning based prediction model for hypertensive disorders of pregnancy (HDP)" O3-13 Kota Fujisawa (Graduate school of Engineering and Science, University of the Ryukyus) "Selecting the genes related to COVID-19 with PCA-based unsupervised feature extraction" |
||||||||||
| 16:15-16:30 | <Closing Remarks> | ||||||||||||
K-01 Toru Natsume (AIST)
K-02 Koichi Takahashi(RIKEN)
K-03 Shigeki Tanishima (Mitsubishi Space Software)
I-01 Masahiro Kino-oka (Osaka University)
I-02 Tomohisa Hasunuma (Kobe University)
I-03 Masahiro Ueda (Osaka University/RIKEN)
I-04 Osamu Nureki (The University of Tokyo)
I-05 Yuji Sugita (RIKEN)
K-04 Tamio Tanikawa (AIST)
K-05 Teruki Honma (RIKEN)
K-06 Ryo Yoshida (The Institute of Statistical Mathematics)
I-06 Hiroki Shirai (Astellas Pharma Co., Ltd.)
I-07 Mari Ito (National Institutes of Biomedical Innovation, Health and Nutrition)
I-08 Haruka Ozaki (University of Tsukuba)
I-09 Shinichiro Fuse (Nagoya University)
I-10 Kanta Ono(High Energy Accelerator Research Organization, KEK)
I-11 Kazunari Kaizu (RIKEN)
I-12 Yusuke Yamada (High Energy Accelerator Research Organization, KEK)
K-07 Hiroshi Tanaka (Emeritus Professor, Tokyo Medical and Dental University /Tohoku Medical Megabank Organization)
K-08 Hiroyuki Kobayashi (Shionogi & Co., Ltd.)
K-09 Ryo Shimizu (Mitsubishi Tanabe Pharma Corp.)
K-10 Shingo Iwami (Kyushu University)
K-11 Satoshi Matsuoka (RIKEN)
K-12 Keita Komatsu (Cabinet Office, Government of Japan)